We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Cyclerion Therapeutics Inc | NASDAQ:CYCN | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.1319 | 4.60% | 3.00 | 1.20 | 3.20 | 3.00 | 2.85 | 2.85 | 481 | 21:06:08 |
|
|
|
(State or other jurisdiction of incorporation)
|
(Commission File Number)
|
(IRS Employer Identification Number)
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
||
|
|
|
Item 5.07. |
Submission of Matters to a Vote of Security Holders.
|
For
|
Against
|
Abstentions
|
Broker Non-Votes
|
|||
1,440,138
|
74,742
|
1,049
|
0
|
For
|
Against
|
Abstentions
|
Broker Non-Votes
|
|||
1,449,712
|
65,191
|
1,026
|
0
|
Item 9.01 |
Financial Statements and Exhibits.
|
Exhibit No.
|
Description
|
104
|
Cover Page Interactive Data File.
|
Cyclerion Therapeutics, Inc.
|
|||
Dated: July 19, 2023
|
By:
|
/s/ Anjeza Gjino
|
|
Name:
|
Anjeza Gjino
|
||
Title:
|
Chief Financial Officer
|
Document and Entity Information |
Jul. 19, 2023 |
---|---|
Cover [Abstract] | |
Document Type | 8-K |
Amendment Flag | false |
Document Period End Date | Jul. 19, 2023 |
Entity File Number | 001-38787 |
Entity Registrant Name | CYCLERION THERAPEUTICS, INC. |
Entity Central Index Key | 0001755237 |
Entity Incorporation, State or Country Code | MA |
Entity Tax Identification Number | 83-1895370 |
Entity Address, Address Line One | 245 First Street, 18th Floor |
Entity Address, City or Town | Cambridge |
Entity Address, State or Province | MA |
Entity Address, Postal Zip Code | 02142 |
City Area Code | 857 |
Local Phone Number | 327-8778 |
Title of 12(b) Security | Common Stock, no par value |
Trading Symbol | CYCN |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | true |
Entity Ex Transition Period | false |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
1 Year Cyclerion Therapeutics Chart |
1 Month Cyclerion Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions